Prof Robyn Guymer to head up new 2RT study for iAMD

Adelaide-based Nova Eye Medical says it has navigated a time-consuming and complex series of conversations with the US Food and Drug Administration (FDA) to pave a clear approval pathway for its pioneering 2RT laser system for selected intermediate age-related macular degeneration (iAMD) patients.
Read More
Robyn Guymer pegcetacoplan

RANZCO updates AMD referral pathway for optometrists

Professor Robyn Guymer has led an expert panel to update RANZCO’s Referral Pathway for Age-Related Macular Degeneration (AMD) Management, which accounts for greater accessibility to retinal imaging equipment and reminds clinicians to be aware of nearby clinical trials.
Read More